Nutriband vs Therapeuticsmd
Therapeuticsmd is the larger business, with $3.0m of revenue in fiscal 2025 against $2.0m for Nutriband (1.5 times as much). Therapeuticsmd grew faster (71.6% against -4.8%). Therapeuticsmd kept more of each dollar of sales as profit: a net margin of -18.8% against -404.1%. Therapeuticsmd carries less debt relative to equity (0.0% against 0.5%).
| Latest fiscal year | NutribandNTRB, 2026 | TherapeuticsmdTXMD, 2025 |
|---|---|---|
| Revenue | $2.0m | $3.0m |
| Revenue growth | -4.8% | 71.6% |
| Net income | −$8.2m | −$569,000 |
| Operating margin | -408.4% | -145.3% |
| Net margin | -404.1% | -18.8% |
| Return on equity | -125.6% | -2.1% |
| Free cash flow | −$5.1m | $2.5m |
| Cash | $4.6m | $7.5m |
| Total debt | $35,861 | $0 |
| Debt to equity | 0.5% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 500 | — |
| Market value | $76.8m | $20.7m |
| Price vs our value range | — | — |
| Moat score | 8 (Weak) | 22 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 1 buys, 0 sales |